Genetic susceptibility to macrovascular complications of type 2 diabetes mellitus
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 15 (3) , 359-370
- https://doi.org/10.1053/beem.2001.0151
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Mutations in the human paraoxonase 1 genePharmacogenetics, 1999
- Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studiesInternational Journal of Clinical and Laboratory Research, 1997
- Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundaryCellular Immunology, 1995
- Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.Journal of Clinical Investigation, 1994
- Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferationJournal of Cellular Biochemistry, 1994
- Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptorFEBS Letters, 1993
- Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- COVALENT STRUCTURE OF FIBRINOGENAnnals of the New York Academy of Sciences, 1983